Phase III trial of pramipexole/rasagiline (P2B 001) in patients with Parkinson's disease.
Phase of Trial: Phase III
Latest Information Update: 30 Jun 2015
At a glance
- Drugs Pramipexole/rasagiline (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Pharma Two B
- 30 Jun 2015 According to a Pharma Two B media release, based on the positive results of the Phase IIb pivotal study (see profile 700238244), the company can now move forward to immediately initiate this trial needed for registration, via the 505(b)(2) pathway.
- 06 Mar 2015 New trial record